Working... Menu

MCLA-117 in Acute Myelogenous Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03038230
Recruitment Status : Recruiting
First Posted : January 31, 2017
Last Update Posted : August 14, 2018
LGC Limited
VU University Medical Center
Pharmaceutical Research Associates
Kinesis Pharma B.V.
CSM Europe sa
QPS Netherlands B.V.
Information provided by (Responsible Party):
Merus N.V.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018